Antifibrinolytic Agent class drugs

10 results

Lysteda (tranexamic acid)

(Tranexamic Acid)
Amring Pharmaceuticals Inc.
Usage: LYSTEDA® is indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential.
Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.
Usage: Tranexamic acid injection, USP is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
Emcure Pharmaceuticals Limited
Usage: Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
Apollo Pharmaceuticals Inc.
Usage: Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
REMEDYREPACK INC.
Usage: Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and minimize the need for replacement therapy during and after tooth extraction.
Sagent Pharmaceuticals
Usage: Tranexamic Acid in Sodium Chloride Injection is indicated for short-term use (2-8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
Zydus Lifesciences Limited
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Tranexamic Acid Injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and minimize the need for replacement therapy during and after tooth extraction.
Avenacy, Inc.
Usage: Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.
Fresenius Kabi USA, LLC
Usage: Tranexamic Acid in Sodium Chloride Injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage and decrease the need for replacement therapy during and after tooth extraction.